154 related articles for article (PubMed ID: 10443661)
1. Anovulation after precocious pubarche: early markers and time course in adolescence.
Ibáñez L; de Zegher F; Potau N
J Clin Endocrinol Metab; 1999 Aug; 84(8):2691-5. PubMed ID: 10443661
[TBL] [Abstract][Full Text] [Related]
2. Early puberty-menarche after precocious pubarche: relation to prenatal growth.
Ibáñez L; Jiménez R; de Zegher F
Pediatrics; 2006 Jan; 117(1):117-21. PubMed ID: 16396868
[TBL] [Abstract][Full Text] [Related]
3. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.
Ibáñez L; Potau N; Marcos MV; De Zegher F
Clin Endocrinol (Oxf); 2000 Oct; 53(4):523-7. PubMed ID: 11012579
[TBL] [Abstract][Full Text] [Related]
4. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.
Ibáñez L; Potau N; Francois I; de Zegher F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3558-62. PubMed ID: 9768664
[TBL] [Abstract][Full Text] [Related]
5. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
Clin Endocrinol (Oxf); 2001 Nov; 55(5):667-72. PubMed ID: 11894979
[TBL] [Abstract][Full Text] [Related]
8. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811
[TBL] [Abstract][Full Text] [Related]
9. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.
Jay N; Mansfield MJ; Blizzard RM; Crowley WF; Schoenfeld D; Rhubin L; Boepple PA
J Clin Endocrinol Metab; 1992 Sep; 75(3):890-4. PubMed ID: 1517382
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
[TBL] [Abstract][Full Text] [Related]
11. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
Ibáñez L; Ong K; de Zegher F; Marcos MV; del Rio L; Dunger DB
Clin Endocrinol (Oxf); 2003 Mar; 58(3):372-9. PubMed ID: 12608944
[TBL] [Abstract][Full Text] [Related]
12. Precocious pubarche in girls and the development of androgen excess.
Ibáñez L; Potau N; Dunger D; de Zegher F
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1261-3. PubMed ID: 11117666
[TBL] [Abstract][Full Text] [Related]
13. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche.
Ibáñez L; Potau N; Zampolli M; Riqué S; Saenger P; Carrascosa A
J Clin Endocrinol Metab; 1997 Jul; 82(7):2283-8. PubMed ID: 9215308
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?
Ibáñez L; Aulesa C; Potau N; Ong K; Dunger DB; de Zegher F
Pediatr Res; 2002 Feb; 51(2):244-8. PubMed ID: 11809921
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
[TBL] [Abstract][Full Text] [Related]
16. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783
[TBL] [Abstract][Full Text] [Related]
17. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2008 May; 93(5):1841-5. PubMed ID: 18319306
[TBL] [Abstract][Full Text] [Related]
18. Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.
Potau N; Williams R; Ong K; Sánchez-Ufarte C; de Zegher F; Ibáñez L; Dunger D
Clin Endocrinol (Oxf); 2003 Dec; 59(6):756-62. PubMed ID: 14974918
[TBL] [Abstract][Full Text] [Related]
19. Reduced ovulation rate in adolescent girls born small for gestational age.
Ibáñez L; Potau N; Ferrer A; Rodriguez-Hierro F; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3391-3. PubMed ID: 12107255
[TBL] [Abstract][Full Text] [Related]
20. Endocrinology and metabolism after premature pubarche in girls.
Ibáñez L; Potau N; De Zegher F
Acta Paediatr Suppl; 1999 Dec; 88(433):73-7. PubMed ID: 10626549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
